| Dr Hua Huang, MD | |
|
136-30 Maple Ave, 2b, Flushing, NY 11355 | |
| (718) 353-8882 | |
| (718) 353-8892 |
| Full Name | Dr Hua Huang |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 136-30 Maple Ave, Flushing, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578509774 | NPI | - | NPPES |
| 02810768 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 224006 (New York) | Secondary |
| 207R00000X | Internal Medicine | 224006 (New York) | Primary |
| Entity Name | Quality Medical Oncology P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477737211 PECOS PAC ID: 3779668298 Enrollment ID: O20080307000543 |
News Archive
What factors are associated with a higher or lower risk of marijuana use among adolescents? There are some important differences for boys versus girls, according to a study in the March Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the fourth quarter and full year ended December 31, 2009. The Company also highlighted recent pipeline progress and outlined expected 2010 milestones.
Scientific evidence links mold and other factors related to damp conditions in homes and buildings to asthma symptoms in some people with the chronic disorder, as well as to coughing, wheezing, and upper respiratory tract symptoms in otherwise healthy people, says a new report from the Institute of Medicine of the National Academies.
The University HealthSystem Consortium (UHC) today announced that it has signed an agreement with ECRI Institute® in Plymouth Meeting, Pa, to offer its academic medical center members special pricing on ECRI's library of current technology research.
Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hua Huang, MD 13630 Maple Ave, 2a, Flushing, NY 11355-3865 Ph: (718) 353-8882 | Dr Hua Huang, MD 136-30 Maple Ave, 2b, Flushing, NY 11355 Ph: (718) 353-8882 |
News Archive
What factors are associated with a higher or lower risk of marijuana use among adolescents? There are some important differences for boys versus girls, according to a study in the March Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the fourth quarter and full year ended December 31, 2009. The Company also highlighted recent pipeline progress and outlined expected 2010 milestones.
Scientific evidence links mold and other factors related to damp conditions in homes and buildings to asthma symptoms in some people with the chronic disorder, as well as to coughing, wheezing, and upper respiratory tract symptoms in otherwise healthy people, says a new report from the Institute of Medicine of the National Academies.
The University HealthSystem Consortium (UHC) today announced that it has signed an agreement with ECRI Institute® in Plymouth Meeting, Pa, to offer its academic medical center members special pricing on ECRI's library of current technology research.
Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.
› Verified 5 days ago
Ms. Min Cai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 College Point Blvd, Suite 1c, Flushing, NY 11355 Phone: 718-321-0558 Fax: 718-321-1672 | |
Dr. David Scott Rubin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13847 Horace Harding Expy, Flushing, NY 11367 Phone: 718-461-5813 Fax: 718-321-8095 | |
Xueshu Zhang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 133-47 Sanford Avenue, Suite 1f, Flushing, NY 11355 Phone: 718-359-5780 Fax: 718-359-5821 | |
Haoxu Ouyang, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13227 41st Rd # 2c, Flushing, NY 11355 Phone: 718-269-5055 | |
Mu-i Karen Kuo, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 13259 41st Rd, Suite Cb, Flushing, NY 11355 Phone: 718-939-6234 Fax: 718-939-6235 | |
Evan Choi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Dr. Mustafa Salehmohamed, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Wa-100, Flushing, NY 11355 Phone: 718-670-1405 |